{
  "id": 16536539,
  "title": "StockWatch: Investment Banker Talks U.S.-Chinese Deals, IPOs, and a Tough Climate for Startups Seeking Capital",
  "url": "https://urgent.news/2026/10/25/stockwatch-investment-banker-talks-u-s-chinese-deals-ipos-and-a-tough",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-25T23:11:05.000Z",
  "source": {
    "name": "GEN Biotechnology",
    "slug": "gen-biotechnology",
    "url": "https://www.genengnews.com/topics/translational-medicine/stockwatch-investment-banker-talks-u-s-chinese-deals-ipos-and-a-tough-climate-for-startups-seeking-capital/"
  },
  "original_language": "en",
  "account": "Geoff Meyerson, CEO of investment bank Locust Walk and its associated investment firm Banyan BioInnovations, discussed the current state of U.S.-Chinese investment deals, IPO activity, and the challenging environment for startups seeking capital in a recent interview with GEN Edge. In 2026, biotech stocks have rebounded from the post-COVID doldrums, with the iShares Biotechnology ETF gaining 34% and the State Street SPDR S&P Biotech ETF rising 39%. The surge in IPOs this year, totaling $7.776 billion, is a 573% increase from 2025's $1.155 billion. Locust Walk's third-quarter market conditions report shows a significant shift in licensing deals, with Chinese companies accounting for 58% of the value, up from 48% a year earlier, while the United States placed second at 26%. M&A activity totaled $42.1 billion across 30 transactions, down from a three-year high of $80.7 billion in 35 transactions during Q2. Despite improving markets, startups are increasingly turning to licensing and collaboration deals, with PIPE activity growing to $3.808 billion across 14 deals, well above the $603 million in Q2 and $1.151 billion in Q3 2025.",
  "summary": "Geoff Meyerson addressed the growth of U.S.-Chinese licensing/collaboration deals, the recent growth of IPOs, and the still-chilly climate for startups seeking financing in a recent interview with GEN Edge. The post StockWatch: Investment Banker Talks U.S.-Chinese Deals, IPOs, and a Tough Climate for Startups Seeking Capital appeared first on GEN - Genetic Engineering and Biotechnology News .",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}